- Home
- SPRY vs GAM Comparison
SPRY vs GAM Comparison
Compare SPRY & GAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SPRY | GAM |
|---|---|---|
| Founded | 2015 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 946.0M | 1.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SPRY | GAM |
|---|---|---|
| Price | $10.51 | $58.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $31.25 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 20.1K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.74% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 11.67 |
| Revenue | ★ $142,772,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $124.59 | N/A |
| P/E Ratio | ★ N/A | $3.95 |
| Revenue Growth | ★ 5459.66 | N/A |
| 52 Week Low | $6.66 | $37.32 |
| 52 Week High | $18.90 | $46.48 |
Technical Indicators
Market Signals| Indicator | SPRY | GAM |
|---|---|---|
| Relative Strength Index (RSI) | 57.53 | 44.96 |
| Support Level | $9.78 | $57.73 |
| Resistance Level | $10.71 | $59.22 |
| Average True Range (ATR) | 0.69 | 0.65 |
| MACD | 0.05 | 0.11 |
| Stochastic Oscillator | 61.32 | 46.36 |
Price Performance
Historical ComparisonAbout SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About GAM General American Investors Inc.
General American Investors Co Inc is a closed-end, diversified management investment company. The primary investment objective of the company is long-term capital appreciation through investment in companies with above-average growth potential. It focuses on equity securities with growth potential at reasonable valuations.